TG THERAPEUTICS, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
TG THERAPEUTICS, INC. (TGTX) had Lessee, Operating Lease, Liability, to be Paid, Year One of $1.97 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-05
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $1.97M.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.97M.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $2.08M.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $2.08M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $1.97M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $1.97M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $2.08M 10-K · filed 2026-02-27 |
| 2025-09-30 | $2.08M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $2.08M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $2.08M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $2.10M 10-K · filed 2025-03-03 |
| 2024-09-30 | $2.10M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $2.10M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $2.10M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $2.39M 10-K · filed 2024-02-29 |
| 2023-09-30 | $2.39M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $2.39M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $2.39M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $2.38M 10-K · filed 2023-03-01 |
| 2022-09-30 | $2.38M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $2.13M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $2.13M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $2.04M 10-K · filed 2022-03-01 |
| 2021-09-30 | $2.04M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $2.04M 10-Q · filed 2021-08-06 |
| 2020-12-31 | $2.01M 10-K · filed 2021-03-01 |
| 2019-12-31 | $1.80M 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |